• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Rumors Of Green Thumb And Boston Beer Merger: What Investors Need to Know, Analyst Breaks It Down

    6/6/24 4:02:22 PM ET
    $CGC
    $SAM
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $CGC alert in real time by email

    Green Thumb Industries (OTC:GTBIF) has expressed interest in merging with Boston Beer (NYSE:SAM), according to a recent report by Pablo Zuanic of Zuanic & Associates. What strategic advantages does this merger offer? How will this impact the profitability of both companies? Could this merger set a precedent for future deals in the cannabis and beverage industries?

    Zuanic’s report presents the implications for investors of this potential merger, as it could reshape the cannabis and beverage sectors.

    $3 Billion In Proforma 2023 Revenues

    Boston Beer shares rose by 30% following a report of Suntory (OTC:STBFY) being in talks to acquire the company. On June 4th, a letter from Green Thumb CEO Ben Kovler to Boston Beer chairman Jim Koch was revealed, expressing interest in a merger. According to the report, despite Green Thumb issuing a statement refusing to comment on market rumors, the details suggest this is more than mere speculation.

    A merger between Green Thumb and Boston Beer would create a company with $3 billion in proforma 2023 revenues, with two-thirds from SAM.

    Zuanic’s report explains SAM's revenues are projected to increase by 2% in 2024, while Green Thumb's are expected to grow by 15%. Despite higher sales, SAM operates in a flat to declining industry, whereas Green Thumb is in a growth sector.

    Green Thumb's 31% adjusted EBITDA margin in 2023 surpasses SAM's 10.5%, highlighting the cannabis company's profitability.

    "While SAM sales are 2x those of Green Thumb, the latter is more profitable. Adjusted EBITDA margins at GTBIF in CY23 were 31% ($326Mn) vs. 10.5% for SAM ($210Mn), with reported gross margins of 50% vs. 42%, respectively. Reported EBIT margins at SAM were 10.5% in 2023 and 17.5% at Green Thumb. For proforma calculations we would estimate at most 3% cost synergies (some back-office functions and corporate overheads), as there is not much overlap," reads the report. 

    Financial Considerations

    Financially, Green Thumb's net debt stood at $147 million at the end of 2023, with a manageable 0.5x EBITDA, while SAM had $298 million in cash and no financial debt.

    According to Zuanic, a cash offer for SAM would significantly increase Green Thumb's leverage, making it an unlikely scenario. An equity-based offer, either 50/50 or 100%, would be more feasible and beneficial for both parties.

    Strategic Benefits And Industry Impact

    The merger would provide SAM with a platform for growth and profitability, while Green Thumb would gain strategic advantages, including an indirect NASDAQ listing.

    Current trading multiples show SAM at 1.3x forward sales and 10.3x EBITDA, compared to Green Thumb at 2.8x and 9x, respectively.

    This potential merger could trigger other consumer packaged goods companies to explore opportunities in the cannabis sector.

    The move aligns with the strategies of companies like Canopy Growth (NASDAQ:CGC) and Tilray (NASDAQ:TLRY), which have made similar moves.

    With federal rescheduling of cannabis likely before January 2025, this could be a critical window for such mergers and acquisitions.

    Learn more about leading cannabis companies and stocks, at the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money, and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!

    Photo: AI-Generated Image. 

    Get the next $CGC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CGC
    $SAM
    $TLRY

    CompanyDatePrice TargetRatingAnalyst
    Tilray Brands Inc.
    $TLRY
    4/3/2026$10.00Neutral → Buy
    Roth Capital
    Tilray Brands Inc.
    $TLRY
    4/2/2026$10.00Neutral → Buy
    Roth Capital
    Canopy Growth Corporation
    $CGC
    3/27/2026Buy
    Canaccord Genuity
    Tilray Brands Inc.
    $TLRY
    1/27/2026Hold
    Canaccord Genuity
    Canopy Growth Corporation
    $CGC
    11/10/2025Sell → Hold
    The Benchmark Company
    Boston Beer Company Inc.
    $SAM
    10/6/2025$235.00Buy → Neutral
    Citigroup
    Boston Beer Company Inc.
    $SAM
    4/2/2025$281.10Hold
    Berenberg
    Boston Beer Company Inc.
    $SAM
    3/20/2025$265.00 → $280.00Neutral → Buy
    Citigroup
    More analyst ratings

    $CGC
    $SAM
    $TLRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/3/26 10:44:58 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/2/26 7:55:13 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Canaccord Genuity initiated coverage on Canopy Growth

    Canaccord Genuity initiated coverage of Canopy Growth with a rating of Buy

    3/27/26 8:46:41 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $CGC
    $SAM
    $TLRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Fisher Cynthia A

    4 - BOSTON BEER CO INC (0000949870) (Issuer)

    4/3/26 9:53:14 AM ET
    $SAM
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 4 filed by Yanofsky Theresa

    4 - Canopy Growth Corp (0001737927) (Issuer)

    4/2/26 4:16:22 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Atkins M Shan

    4 - Canopy Growth Corp (0001737927) (Issuer)

    4/2/26 4:16:02 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $CGC
    $SAM
    $TLRY
    SEC Filings

    View All

    Boston Beer Company Inc. filed SEC Form 8-K: Other Events

    8-K - BOSTON BEER CO INC (0000949870) (Filer)

    4/10/26 4:10:09 PM ET
    $SAM
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form DEFA14A filed by Boston Beer Company Inc.

    DEFA14A - BOSTON BEER CO INC (0000949870) (Filer)

    4/10/26 9:01:56 AM ET
    $SAM
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form DEF 14A filed by Boston Beer Company Inc.

    DEF 14A - BOSTON BEER CO INC (0000949870) (Filer)

    4/10/26 9:00:35 AM ET
    $SAM
    Beverages (Production/Distribution)
    Consumer Staples

    $CGC
    $SAM
    $TLRY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Mongeau Luc bought $49,994 worth of shares (27,469 units at $1.82), increasing direct ownership by 3% to 812,368 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    9/23/25 4:15:11 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Global General Counsel Gendel Mitchell exercised 93,928 shares at a strike of $0.58, covered exercise/tax liability with 49,782 shares and bought $3,496 worth of shares (6,000 units at $0.58), increasing direct ownership by 8% to 698,287 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:06:19 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    President and CEO Simon Irwin D bought $100,106 worth of shares (165,000 units at $0.61), increasing direct ownership by 4% to 3,941,633 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/30/25 6:52:32 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $CGC
    $SAM
    $TLRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TRULY HARD SELTZER BELIEVES U.S. SOCCER WILL WIN THIS SUMMER — AND THEY'RE RENAMING A REAL AMERICAN TOWN TO PROVE IT

    BOSTON, April 08, 2026 (GLOBE NEWSWIRE) -- As the biggest soccer tournament ever arrives on U.S. soil this summer, belief in the American squad has never been stronger. And Truly Hard Seltzer, the Official Hard Seltzer of U.S. Soccer, isn't just predicting a victory – it's putting its faith on full display. With the world's biggest tournament coming to North America, one thing is undeniable: American fans don't just watch the game, they believe in it. They show up with unmatched energy, stand by their team, and back them through every kick until the final whistle. Now, Truly Hard Seltzer is turning that belief into a destination by launching a nationwide search to find one Ameri

    4/8/26 9:01:00 AM ET
    $SAM
    Beverages (Production/Distribution)
    Consumer Staples

    Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced Consumer

    TORONTO, April 08, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. company (NASDAQ:TLRY, TSX:TLRY) a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced the launch of PORTAL™, its newest cannabis brand engineered specifically for seasoned, high‑tolerance consumers seeking uncompromising potency, consistency, and performance, just ahead of 4/20 next month. The vape and infused pre-roll categories have grown rapidly, but with that growth has come sameness. Similar products. Familiar promises. Diminishing returns for consumers who know exactly what they're looking for and rarely find it. PORTAL was created to c

    4/8/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts

    BRECKENRIDGE, Colo., April 07, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), announces the re-launch of Breckenridge Honey Whiskey, a bold new expression infused with Goldswarm Raw Honey from Nigeria. Bottled at 36% ABV (72 proof), the whiskey delivers a rich, smooth, golden finish that is both unmistakable and deeply flavorful. Photo credit: Breckenridge Distillery Originally launched in 2025 in partnership with the Denver Broncos, Breckenridge Honey Whiskey now stands proudly within the Breckenridge Whiskey portfolio. The expression reflects the distillery's commitment to crafting ap

    4/7/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $CGC
    $SAM
    $TLRY
    Financials

    Live finance-specific insights

    View All

    Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026

    NEW YORK and LEAMINGTON, Ontario, March 25, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the Company will release its financial results for the third fiscal quarter which ended February 28, 2026, before the financial markets open on Wednesday, April 1, 2026. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 AM Eastern Time on the same day. The webcast can be accessed on the Events & Presentations section of Ti

    3/25/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region

    Acquisition Includes BrewDog's Profitable Australian Operations Including Brisbane Brewery and Two Flagship Bars Transaction Positions Tilray to Scale BrewDog Across Australia's National Retail and Grocery Channels and Introduce Broader Beverage Portfolio Across Asia-Pacific NEW YORK and BRISBANE, Australia, March 09, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced the completion of the acquisition of BrewDog Brewing Australia Pty Ltd., including BrewDog's Australian brewing and pr

    3/9/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform

    Accretive Acquisition of Select Assets Includes Global Brand, UK Brewing Operations and 11 Strategic Brewpubs  Expected to Generate ~$200 Million in Annual Net Revenue and ~$6 - $8 Million of Adjusted EBITDA in Fiscal 2027 Tilray's Global Consolidated Net Revenue Expected to Reach ~$1.2 Billion on an Annualized Basis1 Conference Call Scheduled for 12:30pm ET NEW YORK and LONDON, March 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today completed the acquisition of certain highly strategic

    3/2/26 10:17:01 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $CGC
    $SAM
    $TLRY
    Leadership Updates

    Live Leadership Updates

    View All

    Canopy Growth Announces Storz & Bickel Executive Transition

    David Männer appointed Managing Director Jürgen Bickel, who co-founded and built Storz & Bickel into a global premium vaporization technology leader, passes the torch following 25 years of transformational leadership Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced the appointment of David Männer as Managing Director of Storz & Bickel, a subsidiary of Canopy Growth, effective April 1, 2026. Mr. Männer succeeds Jürgen Bickel, Storz & Bickel's Co-founder, who has decided to transition out of his role. Founded in 2001, Storz & Bickel has grown into a global leader in vaporization technology. Today, it sets the standard for innovation, p

    3/27/26 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada's Leading Medical Cannabis Business By Revenue

    This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Strengthens Canopy Growth's core Canadian platform, providing additional high-quality flower to support international growth Expected run-rate synergies of approximately $10 million within 18 months Canopy Growth's leadership team and operational depth strengthened through addition of MTL management team members Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) and MTL Cannab

    3/16/26 7:41:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

    BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state. Romano Beverage, a trusted leader in beverage distribution, is now overseeing Breckenridge Distillery's full spirits collection across Illinois—including its celebrated bourbon whiskey, whiskey, rum, vodka, gin, and newly launched Mountain Shot. Romano's strong presence in Illinois and dedication to exceptional service make them the perfect partner to help Breckenridge Distillery thr

    2/4/26 8:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $CGC
    $SAM
    $TLRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Boston Beer Company Inc.

    SC 13G/A - BOSTON BEER CO INC (0000949870) (Subject)

    11/14/24 1:28:28 PM ET
    $SAM
    Beverages (Production/Distribution)
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Boston Beer Company Inc.

    SC 13G/A - BOSTON BEER CO INC (0000949870) (Subject)

    11/12/24 9:50:12 AM ET
    $SAM
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

    SC 13D/A - Canopy Growth Corp (0001737927) (Subject)

    4/19/24 5:00:49 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care